Ponatinib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Ponatinib (coding:ncit:C95777)
RxNorm: ponatinib (coding:rxcui:1364347, coding:omop:45771379)
SNOMED: Ponatinib (coding:sctid:703796003, coding:omop:43013182)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | BCR::ABL1 | Acute Lymphoid Leukemia | Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine | |
| FDA (1) HC (1) | ABL1 p.T315I, BCR::ABL1 | Acute Lymphoid Leukemia | Ponatinib | |
| FDA (1) HC (1) | ABL1 p.T315I | Chronic Myelogenous Leukemia | Ponatinib |